Globus Medical Financial Statements (GMED)
|
|
Report date
|
|
|
17.02.2022 |
31.12.2022 |
21.02.2023 |
16.03.2023 |
21.02.2024 |
|
05.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
958.1 |
1 023 |
1 023 |
1 023 |
1 568 |
|
2 479 |
Operating Income, bln rub |
|
|
172.0 |
236.3 |
228.0 |
228.0 |
133.1 |
|
164.5 |
EBITDA, bln rub |
? |
|
250.3 |
325.5 |
313.8 |
304.5 |
418.2 |
|
526.4 |
Net profit, bln rub |
? |
|
149.2 |
190.2 |
190.2 |
190.2 |
122.9 |
|
91.5 |
|
OCF, bln rub |
? |
|
276.3 |
178.5 |
178.5 |
178.5 |
243.5 |
|
415.0 |
CAPEX, bln rub |
? |
|
56.9 |
74.0 |
74.0 |
74.0 |
78.3 |
|
121.2 |
FCF, bln rub |
? |
|
219.4 |
104.4 |
104.4 |
104.4 |
165.2 |
|
293.8 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
524.0 |
522.9 |
522.9 |
522.9 |
887.2 |
|
1 170 |
Cost of production, bln rub |
|
|
239.2 |
263.7 |
263.7 |
263.7 |
548.2 |
|
1 127 |
R&D, bln rub |
|
|
97.3 |
73.0 |
73.0 |
73.0 |
124.0 |
|
170.0 |
Interest expenses, bln rub |
|
|
9.30 |
14.2 |
14.2 |
14.2 |
0.000 |
|
7.59 |
|
Assets, bln rub |
|
|
1 957 |
2 076 |
2 076 |
2 076 |
5 086 |
|
5 086 |
Net Assets, bln rub |
? |
|
1 741 |
1 846 |
1 846 |
1 846 |
3 998 |
|
4 069 |
Debt, bln rub |
|
|
5.05 |
0.000 |
6.01 |
6.01 |
520.4 |
|
534.6 |
Cash, bln rub |
|
|
443.4 |
446.1 |
446.1 |
446.1 |
517.8 |
|
694.7 |
Net debt, bln rub |
|
|
-438.4 |
-446.1 |
-440.0 |
-440.0 |
2.62 |
|
-160.1 |
|
Ordinary share price, rub |
|
|
72.2 |
74.3 |
74.3 |
74.3 |
53.3 |
|
46.3 |
Number of ordinary shares, mln |
|
|
100.7 |
100.5 |
100.5 |
100.5 |
113.1 |
|
135.6 |
|
Market cap, bln rub |
|
|
7 273 |
7 462 |
7 462 |
7 462 |
6 026 |
|
6 282 |
EV, bln rub |
? |
|
6 835 |
7 016 |
7 022 |
7 022 |
6 029 |
|
6 122 |
Book value, bln rub |
|
|
1 493 |
1 585 |
1 585 |
1 585 |
1 639 |
|
1 795 |
|
EPS, rub |
? |
|
1.48 |
1.89 |
1.89 |
1.89 |
1.09 |
|
0.67 |
FCF/share, rub |
|
|
2.18 |
1.04 |
1.04 |
1.04 |
1.46 |
|
2.17 |
BV/share, rub |
|
|
14.8 |
15.8 |
15.8 |
15.8 |
14.5 |
|
13.2 |
|
EBITDA margin, % |
? |
|
26.1% |
31.8% |
30.7% |
29.8% |
26.7% |
|
21.2% |
Net margin, % |
? |
|
15.6% |
18.6% |
18.6% |
18.6% |
7.83% |
|
3.69% |
FCF yield, % |
? |
|
3.02% |
1.40% |
1.40% |
1.40% |
2.74% |
|
4.68% |
ROE, % |
? |
|
8.57% |
10.3% |
10.3% |
10.3% |
3.07% |
|
2.25% |
ROA, % |
? |
|
7.62% |
9.16% |
9.16% |
9.16% |
2.42% |
|
1.80% |
|
P/E |
? |
|
48.7 |
39.2 |
39.2 |
39.2 |
49.0 |
|
68.6 |
P/FCF |
|
|
33.2 |
71.5 |
71.5 |
71.5 |
36.5 |
|
21.4 |
P/S |
? |
|
7.59 |
7.30 |
7.30 |
7.30 |
3.84 |
|
2.53 |
P/BV |
? |
|
4.87 |
4.71 |
4.71 |
4.71 |
3.68 |
|
3.50 |
EV/EBITDA |
? |
|
27.3 |
21.6 |
22.4 |
23.1 |
14.4 |
|
11.6 |
Debt/EBITDA |
|
|
-1.75 |
-1.37 |
-1.40 |
-1.45 |
0.01 |
|
-0.30 |
|
R&D/CAPEX, % |
|
|
171.1% |
98.6% |
98.6% |
98.6% |
158.4% |
|
140.3% |
|
CAPEX/Revenue, % |
|
|
5.94% |
7.24% |
7.24% |
7.24% |
4.99% |
|
4.89% |
|
Globus Medical shareholders |